Custom Health CEO discusses US expansion after TSX debut - ICYMI

Custom Health Holdings Inc (TSX:CHLT) CEO Shane Bishop talked with Proactive astir the company's technology-enabled pharmacy model, its enlargement strategy and the opportunities up pursuing its caller TSX listing.

Proactive: Welcome backmost wrong our Proactive newsroom. Joining maine contiguous is Shane Bishop, CEO of Custom Health. Shane, large to spot you.

Shane Bishop: Thank you. I admit the invitation and look guardant to the conversation.

Custom Health has an absorbing history. It was founded to lick challenges successful semipermanent healthcare. Can you explicate however the institution began?

I'm a pharmacist by profession, and aboriginal connected we identified a systemic occupation betwixt pharmacy and nursing successful semipermanent attraction astir medicine administration. We developed exertion to amended the accuracy of that process. That archetypal solution remains portion of our concern today, but it besides became the instauration for expanding our exemplary into patients' homes.

The institution has evolved importantly since then. How does Custom Health run today?

We've built infrastructure that connects pharmacies we ain and run with in-home medicine dispensing technology. The instrumentality collects diligent accusation up to 4 times a day, and that accusation flows into our level wherever distant clinicians analyse it. We besides integrate with physics wellness records and physics aesculapian records, allowing america to nonstop real-time recommendations to physicians. Our absorption is delivering proactive diligent care.

What does the diligent acquisition look similar astatine home?

One of our large absorption areas is symptom absorption successful the United States. We've reduced opioid usage among patients by 27%. Prescriptions are filled done our pharmacies, packaged into specialised medicine cartridges and delivered to the patient's home. The dispensing instrumentality releases medicine astatine scheduled times, captures an representation of the medicine for chain-of-custody tracking and asks patients questions, specified arsenic their existent symptom level. About 91% of patients respond. Our clinicians usage that accusation to find whether medicine adjustments whitethorn beryllium due and pass recommendations to physicians to assistance trim addiction hazard portion maintaining effectual symptom management.

Custom Health precocious completed an acquisition. How does that acceptable into the maturation strategy?

We're targeting pharmacy acquisitions successful geographies wherever reimbursement already exists for our model. These are often pharmacies we already enactment with. Owning the pharmacies gives america greater power implicit prime and deployment portion combining acquisition-driven maturation with further diligent measurement flowing into the business. We judge that creates an charismatic and scalable model.